Latest Financials News

AdNeo Limited has completed its acquisition of Learnt Global Group, secured $5.65 million through a placement, and significantly reduced its debt, marking a pivotal step in its growth strategy.

AML3D Limited reported a modest increase in revenue for FY2025 but saw its losses widen significantly, raising questions about its path to profitability.

GWA Group Limited has launched a $30 million on-market share buyback program, balancing capital return with ongoing investment in growth. The move underscores management's confidence in the company’s financial strength and outlook.

Charger Metals has announced a maiden inferred mineral resource of 8.2 million tonnes at 1.0% lithium oxide for its Medcalf Lithium Deposit, underscoring the significant potential of its Lake Johnston project in Western Australia.

GWA Group Limited reported modest revenue and earnings growth for FY2025, underpinned by strong Australian and UK markets, while announcing a $30 million on-market share buyback starting September 2025.

New Hope Corporation reported robust FY25 coal production and EBITDA despite severe weather and logistics disruptions at its Bengalla Mine, while New Acland Mine showed significant growth.

GWA Group Limited has reported a solid FY25 financial performance with modest revenue and profit growth, alongside a dividend increase and a new $30 million share buyback program.

South Harz Potash Limited has closed its shortfall placement, raising A$180,000 and bringing total equity raised to A$2.58 million to fund its dual-asset strategy in Germany.

EcoGraf Limited has been granted its first Australian patent for its innovative HFfree® purification technology, reinforcing its position in the battery anode materials market. This milestone follows a recent breakthrough that cut purification costs by 25%, boosting the commercial potential of its purification facilities.

Silex Systems Limited has announced a Share Purchase Plan (SPP) aiming to raise up to $15 million, offering existing eligible shareholders new shares at a price capped at $3.90 or a 2% discount to recent trading prices. This follows a $130 million institutional placement and supports key commercialisation projects in uranium enrichment.

Lumos Diagnostics has submitted its CLIA waiver application for FebriDx® to the FDA, backed by strong clinical data and triggering significant milestone payments. Approval could expand the U.S. market opportunity fifteen-fold to over $1 billion.

GWA Group Limited reported modest revenue and profit growth for FY2025, driven by disciplined execution amid challenging markets. The company raised its dividend and announced a $30 million on-market share buyback, underscoring confidence in its financial position.